Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Loconsole

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2025
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre studyRiccardo Balestri, Giulia Odorici, Michela Magnano, et al.
Dermatology and Therapy|May 13, 2025
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)Helena Gioacchini, Agnese Rossi, Maria Esposito, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 18, 2025
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world studyLuigi Gargiulo, Silvia M Ferrucci, Luciano Ibba, et al.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life StudyElena Campione, Fabio Artosi, Ruslana Gaeta Shumak, et al.
Expert Opinion on Biological Therapy|November 20, 2020
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational studyMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2025
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre studyRiccardo Balestri, Giulia Odorici, Michela Magnano, et al.
Dermatology and Therapy|May 13, 2025
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)Helena Gioacchini, Agnese Rossi, Maria Esposito, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 18, 2025
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world studyLuigi Gargiulo, Silvia M Ferrucci, Luciano Ibba, et al.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life StudyElena Campione, Fabio Artosi, Ruslana Gaeta Shumak, et al.
Expert Opinion on Biological Therapy|November 20, 2020
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational studyMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi, et al.
Pageof 8